DE69934107D1 - Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen - Google Patents

Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen

Info

Publication number
DE69934107D1
DE69934107D1 DE69934107T DE69934107T DE69934107D1 DE 69934107 D1 DE69934107 D1 DE 69934107D1 DE 69934107 T DE69934107 T DE 69934107T DE 69934107 T DE69934107 T DE 69934107T DE 69934107 D1 DE69934107 D1 DE 69934107D1
Authority
DE
Germany
Prior art keywords
relates
sh3d1a
disorders
gene
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934107T
Other languages
English (en)
Inventor
R Korenberg
Xiao-Ning Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Health System
Original Assignee
Cedars Sinai Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Health System filed Critical Cedars Sinai Health System
Application granted granted Critical
Publication of DE69934107D1 publication Critical patent/DE69934107D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69934107T 1998-04-16 1999-04-16 Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen Expired - Lifetime DE69934107D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8200798P 1998-04-16 1998-04-16
PCT/US1999/008371 WO1999053062A2 (en) 1998-04-16 1999-04-16 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof

Publications (1)

Publication Number Publication Date
DE69934107D1 true DE69934107D1 (de) 2007-01-04

Family

ID=22168041

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934107T Expired - Lifetime DE69934107D1 (de) 1998-04-16 1999-04-16 Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen

Country Status (5)

Country Link
EP (1) EP1071774B1 (de)
JP (1) JP2002511267A (de)
AT (1) ATE346150T1 (de)
DE (1) DE69934107D1 (de)
WO (1) WO1999053062A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036685A2 (en) * 1999-11-17 2001-05-25 Nyxis Neurotherapies, Inc. Differential gene expression in cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378809A (en) * 1992-08-25 1995-01-03 The United States Of America As Represented By The Department Of Health And Human Services Polynucleotides and substrate for the epidermal growth factor receptor kinase (eps8)
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
AU3695099A (en) * 1998-04-27 1999-11-16 Hsc Research And Development Limited Partnership Ese genes and proteins

Also Published As

Publication number Publication date
EP1071774A2 (de) 2001-01-31
EP1071774B1 (de) 2006-11-22
ATE346150T1 (de) 2006-12-15
JP2002511267A (ja) 2002-04-16
WO1999053062A2 (en) 1999-10-21
WO1999053062A3 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
NO982785L (no) Kromosom 13-koblet brystkreftmottagelighetsgen
WO1996005306A3 (en) In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
CA2196795A1 (en) Method for diagnosing a predisposition for breast and ovarian cancer
Marcou et al. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity
Borcherding et al. A transcriptomic map of murine and human alopecia areata
Hoshino et al. X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia
ATE122727T1 (de) Zubereitungen und verfahren für klone, die, mit mehrfacharzneimittelresistenz assoziierte, dna- sequenzen in menschlichen zellen enthalten.
ATE346150T1 (de) Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen
Ali et al. Adult‐onset acute myeloid leukaemia in a patient with germline mutation of CBL.
WO1998025125A3 (en) Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus
MIZUSHIMA et al. Association between gene alteration and drug-sensitivity in human lung-carcinoma cell-lines
Irizarry et al. Leveraging naked mole rat (Heterocephalus glaber) comparative genomics to identify canine genes modulating susceptibility to tumorigenesis and cancer phenotypes.
Smith et al. BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia
Sangatsuda et al. TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3. 3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS
WO2001085911A3 (en) Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
Wozna et al. The immunological, biochemical and molecular bases of canine senescence and carcinogenesis: a review.
박하영 Genetic alterations of NK/T-cell lymphoma
MX9701074A (es) Gen de susceptibilidad al cancer de pecho y ovario enlazado con 17q.
AU3925701A (en) Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
Lam-Po-Tang The Australasian reference thromboplastin (ART)

Legal Events

Date Code Title Description
8332 No legal effect for de